Current AffairsIndia

Centre to buy 30 cr Covid vaccine doses from Hyderabad-based firm

New Delhi: The Centre will procure 30 crore units of Covid-19 vaccine from Hyderabad-based firm Biological-E, an official statement said here on Thursday.

As per the deal, the vaccines doses will be manufactured and stockpiled by the manufacturer from August-December 2021. The Union Ministry of Health would be making an advance payment of Rs 1,500 crore to the firm.

Currently, the vaccine of Biological-E is undergoing Phase-3 clinical trial. The vaccine being developed by Biological-E is a RBD protein sub-unit vaccine and is likely to be available in the next few months, the statement read.

The proposal of M/s Biological-E was examined and recommended for approval after due diligence by National Expert Group on Vaccine Administration for COVID-19 (NEGVAC).

‘The arrangement with M/s Biological-E is part of the wider endeavour of Government of India to encourage indigenous vaccine manufacturers by providing them support in Research & Development (R&D) and also financial support,’ the Ministry said.

Biological-E COVID Vaccine candidate has been supported by the Centre from Preclinical stage to Phase-3 studies. Department of Biotechnology has not only provided financial assistance in terms of grant-in-aid of over Rs 100 cr but has also partnered with Biological-E to conduct all animal challenge and assay studies through its Research Institute Translational Health Science Technology Institute (THSTI), Faridabad.

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker